Clinical Trials
Study Title:
A Phase II/III Randomized Study of R MiniCHOP With or Without CC 486 (Oral Azacitidine) in Patients Age 75 Years or Older With Newly Diagnosed Diffuse Large B Cell Lymphoma, Grade IIIB Follicular Lymphoma, Transformed Lymphoma, and High Grade B Cell Lymphomas With MYC and BCL2 and/or BCL6 Rearrangements
For more information about the trial above please contact the study team:
Medical University of South Carolina Principal Investigator, Brian Hess, at hessbr@musc.edu. Study Coordinator, Sarah Milligan, at millisar@musc.edu.
Trial opened at the following institutions: Medical University of South Carolina |